These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23529605)

  • 41. Bacterial contamination of blood components.
    Engelfriet CP; Reesink HW; Blajchman MA; Muylle L; Kjeldsen-Kragh J; Kekomäki R; Yomtovian R; Höcker P; Stiegler G; Klein HG; Soldan K; Barbara J; Slopecki A; Robinson A; Seyfried H
    Vox Sang; 2000; 78(1):59-67. PubMed ID: 10729814
    [No Abstract]   [Full Text] [Related]  

  • 42. Guidelines for assessing appropriateness of pediatric transfusion.
    Roseff SD; Luban NL; Manno CS
    Transfusion; 2002 Nov; 42(11):1398-413. PubMed ID: 12421212
    [No Abstract]   [Full Text] [Related]  

  • 43. [The risk of substitution therapy with blood and blood products].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1994 Jan; 88(1):3-4. PubMed ID: 8154136
    [No Abstract]   [Full Text] [Related]  

  • 44. [Transfusions of older blood products may pose a risk. Knowledge of storage and transfusion-related injuries is unclear].
    Tornqvist F; Ivarsson KE; Fransson MD; Schmidt-Melbye AC; Algotsson L; Schött U
    Lakartidningen; 2012 Apr 4-10; 109(14-15):754-7. PubMed ID: 22611880
    [No Abstract]   [Full Text] [Related]  

  • 45. Hypersensitivity reactions to blood components: document issued by the allergy committee of the French medicines and healthcare products regulatory agency.
    Mertes PM; Bazin A; Alla F; Bienvenu J; Caldani C; Lamy B; Laroche D; Leconte des Floris MF; Py JY; Rebibo D; Willaert B; Demoly P;
    J Investig Allergol Clin Immunol; 2011; 21(3):171-8. PubMed ID: 21548444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Transfusion and its specific problems in pediatrics and neonatology].
    Pérel Y; Runel C; Huguenin Y; Renesme L; Aladjidi N
    Transfus Clin Biol; 2017 Sep; 24(3):101-105. PubMed ID: 28709844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The risks associated with blood and blood product transfusion.
    Higgins C
    Br J Nurs; 2000 Dec 8-2001 Jan 10; 9(22):2281-90. PubMed ID: 12271194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Developments in blood transfusion].
    Krusius T; Porkka K
    Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306
    [No Abstract]   [Full Text] [Related]  

  • 49. Patient blood management: an update of current guidance in clinical practice.
    Peters J; Pendry K
    Br J Hosp Med (Lond); 2017 Feb; 78(2):88-95. PubMed ID: 28165794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Minimum requirements for the microbiological control of blood components for transfusion. Update of the vote 16].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Mar; 56(3):474-5. PubMed ID: 23455562
    [No Abstract]   [Full Text] [Related]  

  • 51. Current practices in transfusion medicine.
    Borker A; Warrier RP
    Indian Pediatr; 2001 Mar; 38(3):227-30. PubMed ID: 11255297
    [No Abstract]   [Full Text] [Related]  

  • 52. Alternatives to standard blood transfusion: availability and promise.
    Prowse CV
    Transfus Med; 1999 Dec; 9(4):287-99. PubMed ID: 10583882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. European strategies against the parasite transfusion risk.
    Reesink HW
    Transfus Clin Biol; 2005 Feb; 12(1):1-4. PubMed ID: 15814284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Do we have a good blood supply?].
    Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Oct; 56(10):1349-51. PubMed ID: 24162028
    [No Abstract]   [Full Text] [Related]  

  • 55. [Aspects of the risks associated with vCJK from plasma derivatives from human plasma].
    Burger R; Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jun; 52(6):648-9. PubMed ID: 19557456
    [No Abstract]   [Full Text] [Related]  

  • 56. [Update of the votes and 34 35 "method for tracing (lookback) (in accordance with 19 Transfusion Law)" from 14.06.2006 with regard to hepatitis B infection].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Mar; 56(3):476-8. PubMed ID: 23455563
    [No Abstract]   [Full Text] [Related]  

  • 57. [The responsibility of the physician prescriber of blood products].
    Hergon E; Quaranta JF; Moutel G; Hervé C; Rouger P
    Transfus Clin Biol; 2004 Oct; 11(4):221-7. PubMed ID: 15564105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Testing of medicinal products produced from pooled plasma].
    Unkelbach U; Hunfeld A; Breitner-Ruddock S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1181-4. PubMed ID: 25213735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Various methods for good blood supply in Scandinavia].
    Oldinger E
    Nord Med; 1996 Sep; 111(7):212-8. PubMed ID: 8927533
    [No Abstract]   [Full Text] [Related]  

  • 60. The risk of transfusion-transmitted prion infections.
    Rodriguez F; Macalintal Rodriguez N
    MLO Med Lab Obs; 2000 Apr; 32(4):24-8, 30-1. PubMed ID: 10947455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.